A Mouse Model of Airway Disease: Oncostatin M-Induced Pulmonary Eosinophilia, Goblet Cell Hyperplasia, and Airway Hyperresponsiveness Are STAT6 Dependent, and Interstitial Pulmonary Fibrosis Is STAT6 Independent
Open accessThe DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Abstract
Oncostatin M (OSM), a pleiotropic cytokine of the gp130 cytokine family, has been implicated in chronic allergic inflammatory and fibrotic disease states associated with tissue eosinophilia. Mouse (m)OSM induces airway eosinophilic inflammation and interstitial pulmonary fibrosis in vivo and regulates STAT6 activation in vitro. To determine the requirement of STAT6 in OSM-induced effects in vivo, we examined wild-type (WT) and STAT6-knockout (STAT6−/−) C57BL/6 mouse lung responses to transient ectopic overexpression of mOSM using an adenoviral vector (AdmOSM). Intratracheal AdmOSM elicited persistent eosinophilic lung inflammation that was abolished in STAT6−/− mice. AdmOSM also induced pronounced pulmonary remodeling characterized by goblet cell hyperplasia and parenchymal interstitial fibrosis. Goblet cell hyperplasia was STAT6 dependent; however, parenchymal interstitial fibrosis was not. OSM also induced airway hyperresponsiveness in WT mice that was abolished in STAT6−/− mice. OSM stimulated an inflammatory signature in the lungs of WT mice that demonstrated STAT6-dependent regulation of Th2 cytokines (IL-4, IL-13), chemokines (eotaxin-1/2, MCP-1, keratinocyte chemoattractant), and extracellular matrix modulators (tissue inhibitor of matrix metalloproteinase-1, matrix metalloproteinase-13), but STAT6-independent regulation of IL-4Rα, total lung collagen, collagen-1A1, -1A2 mRNA, and parenchymal collagen and α smooth muscle actin accumulation. Thus, overexpression of mOSM induces STAT6-dependent pulmonary eosinophilia, mucous/goblet cell hyperplasia, and airway hyperresponsiveness but STAT6-independent mechanisms of lung tissue extracellular matrix accumulation. These results also suggest that eosinophil or neutrophil accumulation in mouse lungs is not required for OSM-induced lung parenchymal collagen deposition and that OSM may have unique roles in the pathogenesis of allergic and fibrotic lung disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“STAT is a downstream signaling molecule from JAK activation with seven subtypes: phosphorylated STAT-3 is elevated in biopsies of patients with IPF and in mice with bleomycin induced pulmonary fibrosis. [174–177]”
From Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF) (2024) · cites this paper as [175]
Citations
Cites
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
HEINRICH, P. C., BEHRMANN, I., HAAN, S., HERMANNS, H. M., MÜLLER-NEWEN, G., & SCHAPER, F. (2003) · Biochemical Journal · doi:10.1042/bj20030407 · Cited by 3,272
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
HEINRICH, P. C., BEHRMANN, I., MÜLLER-NEWEN, G., SCHAPER, F., & GRAEVE, L. (1998) · Biochemical Journal · doi:10.1042/bj3340297 · Cited by 2,130
Requirement for IL-13 Independently of IL-4 in Experimental Asthma
Grünig, G., Warnock, M., Wakil, A. E., Venkayya, R., Brombacher, F., Rennick, D. M., Sheppard, D., Mohrs, M., Donaldson, D. D., Locksley, R. M., et al. (1998) · Science · doi:10.1126/science.282.5397.2261 · Cited by 1,849
Zhu, Z., Homer, R. J., Wang, Z., Chen, Q., Geba, G. P., Wang, J., Zhang, Y., & Elias, J. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5909 · Cited by 1,719
Asthma: From Bronchoconstriction to Airways Inflammation and Remodeling
BOUSQUET, J., JEFFERY, P. K., BUSSE, W. W., JOHNSON, M., & VIGNOLA, A. M. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.5.9903102 · Cited by 1,702 · cited 4×
“Because subepithelial membrane fibrosis is another characteristic of airway remodeling in asthma (55), we also examined collagen deposition in this locale in WT and STAT6 mice (Figs.”
BackgroundInfluentialgp 130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINES
Taga, T., & Kishimoto, T. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.797 · Cited by 1,461
WENZEL, S. E., SCHWARTZ, L. B., LANGMACK, E. L., HALLIDAY, J. L., TRUDEAU, J. B., GIBBS, R. L., & CHU, H. W. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.3.9812110 · Cited by 1,235 · cited 1×
“Accumulation of inflammatory cells including eosinophils is thought to contribute to subepithelial basement membrane remodeling (37, 38) and AHR (39, 40) in asthmatics and pulmonary fibrosis and reduced diffusion capacity (41, 42) in subjects with IPF.”
BackgroundWardlaw, A. J., Dunnette, S., Gleich, G. J., Collins, J. V., & Kay, A. B. (1988) · American Review of Respiratory Disease · doi:10.1164/ajrccm/137.1.62 · Cited by 907 · cited 14×
“Accumulation of inflammatory cells including eosinophils is thought to contribute to subepithelial basement membrane remodeling (37, 38) and AHR (39, 40) in asthmatics and pulmonary fibrosis and reduced diffusion capacity (41, 42) in subjects with IPF.”
BackgroundInfluentialA Critical Role for Eosinophils in Allergic Airways Remodeling
Humbles, A. A., Lloyd, C. M., McMillan, S. J., Friend, D. S., Xanthou, G., McKenna, E. E., Ghiran, S., Gerard, N. P., Yu, C., Orkin, S. H., et al. (2004) · Science · doi:10.1126/science.1100283 · Cited by 862 · cited 1×
“Several animal studies of asthma utilizing selective eosinophil-depletion strategies have linked this leukocyte population with the development of mucous/goblet cell hyperplasia (56, 57); however, others have not (58).”
BackgroundValidation of rheumatoid arthritis improvement criteria that include simplified joint counts
van Gestel, A. M., Haagsma, C. J., & van Riel, P. L. C. M. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199810)41:10<1845::aid-art17>3.0.co;2-k · Cited by 803
Cited by
Kiryluk, K., Li, Y., Scolari, F., Sanna-Cherchi, S., Choi, M., Verbitsky, M., Fasel, D., Lata, S., Prakash, S., Shapiro, S., et al. (2014) · Nature Genetics · doi:10.1038/ng.3118 · Cited by 628
Therapeutic targets in lung tissue remodelling and fibrosis
Liu, G., Philp, A. M., Corte, T., Travis, M. A., Schilter, H., Hansbro, N. G., Burns, C. J., Eapen, M. S., Sohal, S. S., Burgess, J. K., et al. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107839 · Cited by 249
Pothoven, K. L., Norton, J. E., Hulse, K. E., Suh, L. A., Carter, R. G., Rocci, E., Harris, K. E., Smith, S. S., Conley, D. B., Chandra, R. K., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.01.043 · Cited by 158
“Moreover, intratracheal administration of adenoviral OSM to mice was shown to be sufficient to induce a type 2 immune response in the lung that was characterized by goblet cell hyperplasia; formation of bronchial-associated lymphoid tissue; eosinophil infiltration; production of IL-4, IL-5, IL-13, and eotaxins; and ai…”
BackgroundAyaub, E. A., Dubey, A., Imani, J., Botelho, F., Kolb, M. R. J., Richards, C. D., & Ask, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-13511-z · Cited by 120
Self-citationCytokines and STATs in Liver Fibrosis
Kong, X., Horiguchi, N., Mori, M., & Gao, B. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00069 · Cited by 113
“Finally, in lung fibrosis, two studies showed that STAT6-deficient mice still develop into fibrosis in two murine models induced by transient ectopic overexpression of oncostatin M (Fritz et al., 2011) or by an intratracheal challenge with live A.”
BackgroundRole of neutrophils in allergic asthma
Radermecker, C., Louis, R. E., Bureau, F., & Marichal, T. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.05.006 · Cited by 104
“The exact contribution of oncostatin M to allergic asthma is still unclear, but endotracheal treatment of mice with adenovirus expressing mouse oncostatin-M has been shown to be sufficient to promote features of allergic asthma [55].”
BackgroundSugita, K., & Kabashima, K. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.5mr0120-230r · Cited by 110
Rahman, L., Jacobsen, N. R., Aziz, S. A., Wu, D., Williams, A., Yauk, C. L., White, P. A., Wallin, H., Vogel, U. B., & Halappanavar, S. S. (2017) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2017.08.005 · Cited by 105
Fibulin-1c regulates transforming growth factor–β activation in pulmonary tissue fibrosis
Liu, G., Cooley, M. A., Jarnicki, A., Borghuis, T., Nair, P. M., Tjin, G., Hsu, A., Haw, T. J., Fricker, M., Harrison, C. L., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.124529 · Cited by 110
“Tissue damping is a measure of whole lung tissue resistance, while tissue elastance and compliance indicate the level of lung stiffness (32).”
BackgroundSingh, S. P., Gundavarapu, S., Peña-Philippides, J. C., Rir-sima-ah, J., Mishra, N. C., Wilder, J. A., Langley, R. J., Smith, K. R., & Sopori, M. L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101567 · Cited by 93
“2/MAPK pathway, independent of STAT6 (68, 69), STAT6 also controls Th2 cytokines and goblet cell metaplasia (70).”
BackgroundIL-13 Signaling in Liver Fibrogenesis
Liu, Y., Munker, S., Müllenbach, R., & Weng, H.-L. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00116 · Cited by 91
“Stat6 activation upon receptor engagement is suggested due to the recruitment of Stat6 to the IL-4Rα chain (Kelly-Welch et al., 2003).”
BackgroundInfluentialThe cytokines of pulmonary fibrosis: Much learned, much more to learn
Luzina, I. G., Todd, N. W., Sundararajan, S., & Atamas, S. P. (2014) · Cytokine · doi:10.1016/j.cyto.2014.11.008 · Cited by 100
Pothoven, K. L., & Schleimer, R. P. (2017) · Tissue Barriers · doi:10.1080/21688370.2017.1341367 · Cited by 98
“In a mouse model, intratracheal administration of adenoviral expressed OSM was shown to be sufficient to induce robust type 2 inflammation in the lung, without any specific antigen challenge.(86,87) Studies using reconstituted epidermis have shown that OSM treatment decreased expression of filaggrin, a molecule that i…”
MethodOncostatin M and its role in fibrosis
Stawski, L., & Trojanowska, M. (2019) · Connective Tissue Research · doi:10.1080/03008207.2018.1500558 · Cited by 86
Cytokines in chronic respiratory diseases
Atamas, S. P., Chapoval, S. P., & Keegan, A. D. (2013) · F1000 Biology Reports · doi:10.3410/b5-3 · Cited by 91
“The chemokine monocyte chemotactic protein (MCP)-1/ CCL2 promotes fibrosis through direct and indirect mechanisms [157-160], as do Oncostatin M [128,161] and platelet derived growth factor (PDGF) [162-164].”
BackgroundYazıcı, D., Öğülür, İ., Pat, Y., Babayev, H., Barletta, E., Ardıçlı, S., Imam, M. B., Huang, M., Koch, J., Li, M., et al. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101846 · Cited by 81
Kanda, N., & Watanabe, S. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.10.010 · Cited by 65
Kanda, N., Hau, C. S., Tada, Y., Sato, S., & Watanabe, S. (2012) · Allergy · doi:10.1111/j.1398-9995.2012.02824.x · Cited by 66
IL-6 family cytokines in respiratory health and disease
Dawson, R., Jenkins, B. J., & Saad, M. I. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155520 · Cited by 74
Pohin, M., Guesdon, W., Mekouo, A. A. T., Rabeony, H., Pâris, I., Atanassov, H., Favot, L., Mcheik, J. N., Bernard, F., Richards, C. D., et al. (2016) · European Journal of Immunology · doi:10.1002/eji.201546216 · Cited by 66
Self-citationHeadland, S. E., Dengler, H. S., Xu, D., Teng, G., Everett, C., Ratsimandresy, R. A., Yan, D., Kang, J., Ganeshan, K., Nazarova, E. V., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abf8188 · Cited by 60
“These data, and previous studies with adenoviral vectors overexpressing OSM leading to increased mucus (54), indicate that OSM both can contribute to mucus hypersecretion and is necessary for mucus secretion in allergen-exposed mice.”
ResultSTAT3: A Central Mediator of Pulmonary Fibrosis?
Prêle, C. M., Yao, E., O’Donoghue, R. J. J., Mutsaers, S. E., & Knight, D. A. (2012) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201201-007aw · Cited by 53
Fstl1 Promotes Asthmatic Airway Remodeling by Inducing Oncostatin M
Miller, M., Beppu, A., Rosenthal, P., Pham, A. K., Das, S., Karta, M. R., Song, D. J., Vuong, C., Doherty, T. A., Croft, M., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501105 · Cited by 49
“In addition, adenoviral-mediated overexpression of OSM in the lungs of WT mice (33) results in the features we have noted to be induced by Fstl1 in this study including increased fibrosis, goblet cell hyperplasia, eosinophilic inflammation, and AHR, supporting our observations that OSM mediates the effects of Fstl1 on”
ResultHuang, W., Wu, S., Tu, R.-S., Lai, Y.-R., & Liou, C. (2015) · Food & Function · doi:10.1039/c5fo00149h · Cited by 51
Botelho, F. M., Rangel‐Moreno, J., Fritz, D. K., Randall, T. D., Xing, Z., & Richards, C. D. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203318 · Cited by 55
“In addition, our observations in the mouse are not restricted to Ad vector–induced OSM effects, because Mozaffarian et al. (11) have found effects in eosinophil accumulation or extracellular matrix accumulation after 10 d of administration of recombinant OSM protein (2 mg daily) that resemble the observations we have…”
BackgroundMethodResultSelf-citationWong, S. C., Botelho, F. M., Rodrigues, R., & Richards, C. D. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.81 · Cited by 55
Self-citationBoué, S., León, H. D., Schlage, W. K., Peck, M. J., Weiler, H., Berges, A., Vuillaume, G., Martin, F. P., Friedrichs, B., Lebrun, S., et al. (2013) · Toxicology · doi:10.1016/j.tox.2013.09.013 · Cited by 51
Traber, K. E., Hilliard, K. L., Allen, E., Wasserman, G. A., Yamamoto, K., Jones, M. R., Mizgerd, J. P., & Quinton, L. J. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2014-0342oc · Cited by 45
“It has also been shown that overexpression of OSM using adenovirus encoding OSM results in an increase in neutrophils, macrophages, and eosinophils after 7 days (30, 41).”
MethodInnate Immune Cytokines, Fibroblast Phenotypes, and Regulation of Extracellular Matrix in Lung
Richards, C. D. (2017) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2016.0112 · Cited by 42
Self-citationMacrophage-derived oncostatin M repairs the lung epithelial barrier during inflammatory damage
Hoagland, D. A., Rodríguez-Morales, P., Mann, A. O., Vazquez, A. Y. B., Yu, S., Lai, A., Kane, H., Dang, S. M., Lin, Y., Thorens, L., et al. (2025) · Science · doi:10.1126/science.adi8828 · Cited by 45
Novel function of Oncostatin M as a potent tumour‐promoting agent in lung
Lauber, S., Wong, S. C., Cutz, J., Tanaka, M., Barra, N. G., Lhoták, Š., Ashkar, A. A., & Richards, C. D. (2014) · International Journal of Cancer · doi:10.1002/ijc.29055 · Cited by 39
“OSM over-expression in mouse lung using adenovirus vector encoding murine OSM (AdOSM) induces transient inflammation and collagen accumulation.(18,19) The initial discovery of OSM characterised its activity as a direct inhibitor of melanoma cell line growth in human systems.”
BackgroundMethodSelf-citationHuguier, V., Giot, J., Simonneau, M., Levillain, P., Charreau, S., Garcia, M., Jégou, J., Bodet, C., Morel, F., Lecron, J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-38572-0 · Cited by 39
Oncostatin M in the Regulation of Connective Tissue Cells and Macrophages in Pulmonary Disease
Richards, C. D., & Botelho, F. M. (2019) · Biomedicines · doi:10.3390/biomedicines7040095 · Cited by 37
“In the mouse, such accumulation requires the action of additional pathways in vivo, since eotaxin-1 protein levels and eosinophil accumulation in broncho-alveolar lavage fluid (BALF) were absent in STAT6-deficient mice, implicating dependency on IL-4 or IL-13 and their canonical STAT6 signaling pathway [17].”
BackgroundSelf-citationRegulation of pulmonary inflammation by mesenchymal cells
Alkhouri, H., Poppinga, W. J., Tania, N. P., Ammit, A. J., & Schuliga, M. J. (2014) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2014.03.001 · Cited by 35
Wang, B.-F., Cao, P., Norton, J. E., Poposki, J. A., Klingler, A. I., Suh, L. A., Carter, R., Huang, J. H., Bai, J., Stevens, W. W., et al. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.11.029 · Cited by 33
Association of variants in innate immune genes with asthma and eczema
Sharma, S., Poon, A. H., Himes, B. E., Lasky-Su, J. A., Sordillo, J. E., Belanger, K. D., Milton, D. K., Bracken, M. B., Triche, E. W., Leaderer, B. P., et al. (2011) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.2011.01243.x · Cited by 29
Preusch, M. R., Ieronimakis, N. M., Wijelath, E. S., Ricks, J. L., Bea, F., Reyes, M., van Ryn, J., Rosenfeld, M. E., & Cabbage, S. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s86969 · Cited by 34
“18,19 Kastl et al demonstrated that thrombin stimulates OSM expression in human carotid plaque macrophages.”
Mast cells disrupt the function of the esophageal epithelial barrier
Kleuskens, M. T. A., Bek, M. K., Halabi, Y. A., Blokhuis, B. R. J., Diks, M. A. P., Haasnoot, M. L., Garssen, J., Bredenoord, A. J., van Esch, B. C. A. M., & Redegeld, F. A. (2023) · Mucosal Immunology · doi:10.1016/j.mucimm.2023.06.001 · Cited by 31
Histamine up‐regulates oncostatin M expression in human M1 macrophages
Mommert, S., Hüer, M., Schaper‐Gerhardt, K., Gutzmer, R., & Werfel, T. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14796 · Cited by 28
Ophiocordyceps lanpingensis polysaccharides attenuate pulmonary fibrosis in mice
Zhou, S., Zhou, Y., Yu, J., Du, Y., Tan, Y., Ying-Mei, K. E., Wang, J., Han, B., & Ge, F. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110058 · Cited by 28
Dumas, A., Lagarde, S., Laflamme, C., & Pouliot, M. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01412.x · Cited by 28
Richards, C. D., Gandhi, R., Botelho, F. M., Ho, L., & Paolini, J. F. (2020) · Acta Dermato Venereologica · doi:10.2340/00015555-3505 · Cited by 23
“In other experimental systems, OSM has been shown to increase IL-4 and IL-13 expression and upregulate their corresponding receptors IL-4Rα and IL-13Rα (9, 12, 29, 30, 32, 33, 34).”
BackgroundInfluentialSelf-citationIL-33 Mediates Lung Inflammation by the IL-6-Type Cytokine Oncostatin M
Botelho, F. M., Dubey, A., Ayaub, E. A., Park, R., Yip, A., Humbles, A. A., Kolbeck, R., & Richards, C. D. (2020) · Mediators of Inflammation · doi:10.1155/2020/4087315 · Cited by 26
“AdOSM induced the upregulation of col1A1, col3A1, MMP-13, and TIMP-1 as previously described [19, 22, 30] and was reduced in whole lung extracts of IL-33-/- mice (Figure 6).”
BackgroundMethodSelf-citationCurrent and emerging biologic and small molecule therapies for atopic dermatitis
Li, R., Hadi, S. M., & Guttman‐Yassky, E. (2019) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2019.1573422 · Cited by 22
“Activation of type II OSMR leads to a proinflammatory response characterized by an increased production of Th2 cytokines (IL-4 and IL-13) and chemokines (eotaxin-1/2, MCP-1) [82].”
Regulation of IL-33 by Oncostatin M in Mouse Lung Epithelial Cells
Richards, C. D., Izakelian, L., Dubey, A., Zhang, G. Y., Wong, S. C., Kwofie, K., Qureshi, A., & Botelho, F. M. (2016) · Mediators of Inflammation · doi:10.1155/2016/9858374 · Cited by 24
“Adenovirus encoding mouse OSM (AdOSM) or empty virus (AdDel70) has been previously described and was used to transiently express virus encoded genes in lungs by endotracheal administration as previously indicated [30, 31].”
Self-citationAkkenepally, S. V., Yombo, D. J. K., Yerubandi, S., Reddy, G. B., Deshpande, D. A., McCormack, F. X., & Madala, S. K. (2023) · Nature Communications · doi:10.1038/s41467-023-44040-1 · Cited by 19
“IL-6, oncostatin M (OSM ), and IL-31 are members of the IL-6 familyofcytokinesknowntoregulateAHRinallergicasthma 41 – 43 .”
Lee, D. C. P., Walker, S. A., Byrne, A. J., Gregory, L. G., Buckley, J., Bush, A., Shaheen, S. O., Saglani, S., & Lloyd, C. M. (2015) · Thorax · doi:10.1136/thoraxjnl-2014-205280 · Cited by 17
Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF)
Aribindi, K., Liu, G. Y., & Albertson, T. E. (2024) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2024.2396121 · Cited by 17
Role of oncostatin M in the pathogenesis of vernal keratoconjunctivitis: focus on tissue remodeling
Mashimo, K., Usui‐Ouchi, A., Ito, Y., Wakasa, R., Yokoi, N., Kawasaki, S., Murakami, A., Matsuda, A., & Ebihara, N. (2021) · Japanese Journal of Ophthalmology · doi:10.1007/s10384-020-00791-8 · Cited by 14
“Moreover, intratracheal administration of adenoviral OSM to mice was shown to induce a type 2 immune response [4].”
BackgroundTargetable pathogenic mechanisms in nasal polyposis
Schneider, A. L., Schleimer, R. P., & Tan, B. K. (2021) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22787 · Cited by 12
Oncostatin M Induces a Pro-inflammatory Phenotype in Intestinal Subepithelial Myofibroblasts
Kokkotis, G., Filidou, E., Tarapatzi, G., Spathakis, M., Kandilogiannakis, L., Dovrolis, N., Arvanitidis, K. I., Drygiannakis, I., Valatas, V., Vradelis, S., et al. (2024) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izae098 · Cited by 11
Hoermann, G., Cerny‐Reiterer, S., Sadovnik, I., Müllauer, L., Bilban, M., Gröger, M., Horny, H. ‐., Reiter, A., Schmitt-Graeff, A. H., Mannhalter, C., et al. (2013) · Allergy · doi:10.1111/all.12139 · Cited by 11
“Moreover, intranasal administration of OSM resulted in marked eosinophilic inflammation and consecutive collagen deposition and fibrosis in the lung of C57BL/6 mice (21, 23).”
BackgroundBotelho, F. M., Rodrigues, R., Guerette, J., Wong, S. C., Fritz, D. K., & Richards, C. D. (2019) · Cells · doi:10.3390/cells8020126 · Cited by 11
“Such results in C57Bl/6 mice were also consistent with subsequent data showing that the AdOSM-induced elevation of ECM was independent of STAT6, a major signaling pathway of both IL-4 and IL-13 but was required for the effects on eosinophil accumulation [23].”
BackgroundMethodResultSelf-citationHo, L., Yip, A., Lao, F., Botelho, F. M., & Richards, C. D. (2020) · Cells · doi:10.3390/cells9061338 · Cited by 11
“To examine the in vivo regulation of RELMα, C57Bl/6 were endo-tracheally administered with PBS, the empty control vector AdDel70, or AdOSM to induce transient overexpression of mOSM as previous [13,36,37] in the lungs for seven or 14 days.”
BackgroundMethodSelf-citationOncostatin M Mediates Adipocyte Expression and Secretion of Stromal-Derived Factor 1
Hang, H., Bailey, J. L., & Elks, C. M. (2019) · Biology · doi:10.3390/biology8010019 · Cited by 7
Ninomiya, I., Yamatoya, K., Mashimo, K., Matsuda, A., Usui‐Ouchi, A., Araki, Y., & Ebihara, N. (2022) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.63.13.26 · Cited by 8
Shivshankar, P., Payan, H., CALHOUN, C. L., Levine, S. M., Williams, R. O., Jagirdar, J. S., Peters, J. I., & Saux, C. J. L. (2014) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(14)50090-1 · Cited by 5
Bronchial hyperreactivity: pathogenesis and treatment options
Antošová, M., Strapková, A., & Plevková, J. (2011) · Open Journal of Molecular and Integrative Physiology · doi:10.4236/ojmip.2011.13007 · Cited by 5
“It was also determined that oncostatine M, a pleiotropic cytokine of the gp 130 cytokine family is implicated in chronic allergic diseases, including airway remodelling [30].”
BackgroundIshikawa, C., Takeno, S., Okamoto, Y., Kawasumi, T., Kakimoto, T., Takemoto, K., Nishida, M., Ishino, T., Hamamoto, T., Ueda, T., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11123224 · Cited by 4
Type I Interferon Signaling is Required for Oncostatin-M Driven Inflammatory Responses in Mouse Lung
MacDonald, K., Botelho, F. M., Ashkar, A. A., & Richards, C. D. (2022) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2022.0136 · Cited by 4
Self-citationLauber, S. (2012) · MacSphere (McMaster University) · doi:10.71548/15037 · Cited by 2
Augustine, M., Nene, N. R., Fu, H., Pinder, C. L., Ligammari, L., Simpson, A. P., Sanz-Fernández, I., Thakkar, K., Qian, D., Fitzsimons, E., et al. (2026) · Nature Machine Intelligence · doi:10.1038/s42256-026-01201-3 · Cited by 3
“44).”
Interleukin 31 receptor alpha induces airway hyperresponsiveness in asthmaPreprint
Akkenepally, S., Yombo, D. J. K., Yerubandi, S., Geereddy, B. R., McCormack, F. X., & Madala, S. K. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.15.520615
Impact of Obesity on the Structured Histopathology of Chronic Rhinosinusitis Patients
Ma, D. X., Neerumalla, S., Baird, A. M., Whitehead, R. A., Filip, P., Tajudeen, B. A., Batra, P. S., & Papagiannopoulos, P. (2025) · The Laryngoscope · doi:10.1002/lary.70177
“Finally, recent studies by Fritz et al. [22] demonstrated OSM stimulates the development of goblet cell hyperplasia in the mouse model.”
Ratsimandresy, R. A., Doran, E., Dengler, H. S., Headland, S. E., Wedeles, C. J., Guidi, R., Xu, D., Liu, J., Shi, Y., Wang, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.25.695625
Chen, G., Huang, C., Wang, Z., Gu, W., Jie, H., Xiong, T., Liu, Y., Feng, Y., Yi, L., Xue, Z., et al. (2026) · Experimental Cell Research · doi:10.1016/j.yexcr.2026.114953
Rôle de l'oncostatine M et des interleukines 6 et 31 dans l'inflammation cutanée chez la souris
Pohin, M. (2017) · theses.fr (ABES) · doi:10.70675/6ee5de11z33c0z4d68z9887z2c7a7194291a
Simonneau, M. (2018) · theses.fr (ABES) · doi:10.70675/34bc0b41z17a7z49e0zb6c5zd874a4c8cbeb · Cited by 1
Cytokines with pro- and antiinflammatory activities
Dembić, Z. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45128-7.00015-7
Metadata
- Authors
- Fritz, D. K., Kerr, C., Fattouh, R., Llop-Guevara, A., Khan, W. I., Jordana, M., & Richards, C. D.
- Affiliations
- McMaster University (CA)
- Department of Pathology and Molecular Medicine, McMaster University , Hamilton, Ontario ,
- Corresponding author
- Kerr, Christine
- Fattouh, Ramzi
- Jordana, Manel
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-01
- Volume
- 186
- Issue
- 2
- Pages
- 1107-1118
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2159014577
- Cited by
- 69
- References
- 84
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 2 · 2023: 5 · 2022: 4 · 2021: 4 · 2020: 5 · 2019: 7 · 2018: 3 · 2017: 5 · 2016: 2 · 2015: 6 · 2014: 6 · 2013: 4 · 2012: 5
- FWCI
- 3.03
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Keywords
- oncostatin M, STAT6, pulmonary eosinophilia, goblet cell hyperplasia, airway hyperresponsiveness, interstitial pulmonary fibrosis, allergic airway disease, gp130 cytokines, Th2 cytokines, extracellular matrix deposition, collagen deposition, adenoviral overexpression, lung remodeling
- MeSH terms
- Adenoviridae, Animals, Disease Models, Animal, Extracellular Matrix, Female, Genetic Vectors, Hyperplasia, Mice, Inbred C57BL, Pulmonary Eosinophilia, Pulmonary Fibrosis, Bronchial Hyperreactivity, Lung Diseases, Interstitial, Mice, Knockout, Goblet Cells, STAT6 Transcription Factor, Mice, Oncostatin M
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.